Related Experiment Video
Updated: Jul 6, 2026
12:42
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Enhancing poxvirus oncolytic effects through increased spread and immune evasion
David H Kirn1, Yaohe Wang, Wenchung Liang
1Jennerex Biotherapeutics, Ltd., San Francisco, California, USA.
Cancer Research
|April 3, 2008
Summary
Extracellular enveloped virus (EEV) enhanced vaccinia virus strains show improved tumor spread and systemic delivery, leading to better oncolytic effects. This strategy enhances viral potency against tumors without compromising safety.
Area of Science:
- Virology
- Immunology
- Oncology
Background:
- Oncolytic virus therapy faces challenges with tumor cell spread and systemic delivery, especially in pre-immunized patients.
- Tumor-selective poxviruses show promise, but physical barriers and neutralizing antibodies hinder efficacy.
- Extracellular enveloped virus (EEV) is a naturally occurring poxvirus form with enhanced systemic spread and immune evasion capabilities.
Purpose of the Study:
- To investigate the potential of extracellular enveloped virus (EEV)-enhanced vaccinia virus strains for improved oncolytic virotherapy.
- To evaluate the impact of EEV enhancement on viral spread within tumors and systemic delivery.
- To assess the ability of EEV-enhanced strains to overcome immune clearance and physical barriers.
Main Methods:
- Comparison of low and high EEV-producing vaccinia virus strains in preclinical models.
- Assessment of intratumoral and systemic viral spread following administration.
- Evaluation of antitumor efficacy and viral clearance in the presence of neutralizing antibodies.
Main Results:
- EEV-enhanced vaccinia strains demonstrated significantly improved spread within tumors after systemic delivery.
- These enhanced strains showed superior ability to spread to distant, non-injected tumors via the bloodstream.
- EEV-enhanced vaccinia exhibited reduced clearance by neutralizing antibodies, improving systemic delivery and efficacy.
- Viral safety profiles remained comparable to non-enhanced strains.
Conclusions:
- Enhancing vaccinia virus with extracellular enveloped virus (EEV) improves oncolytic virotherapy by facilitating systemic spread and tumor penetration.
- EEV-enhanced strains offer a promising strategy to overcome key limitations in oncolytic virus delivery and efficacy.
- Incorporating EEV-enhancing mutations into future oncolytic vaccinia virus designs may significantly boost therapeutic potency without compromising safety.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:51Mechanisms of Retrovirus-induced Cancers
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
01:51Mechanisms of Retrovirus-induced Cancers
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:29Immune Response Against Viral Pathogens
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...